Remus Pharmaceuticals P/E Ratio

Current P/E Ratio
20.8
Moderate Valuation
High - Growth expectations or overvalued

Remus Pharmaceuticals P/E ratio. Remus Pharmaceuticals (REMUS) P/E ratio is 20.8 (Moderate), EPS (TTM) ₹39.19, current price ₹ on None — High - Growth expectations or overvalued. Check REMUS company valuation to track the company's total market size over time.

Current Valuation Metrics

P/E Ratio 20.8
Current Price ₹
EPS (TTM) ₹39.19
Exchange None

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 52.32
Sector Median 29.6
Sector Rank #11 of 255
Sector Percentile 4.3%

REMUS P/E Ratio — Valuation Signal & Historical Context

Remus Pharmaceuticals P/E 20.8 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see REMUS stock price BSE.

  • Trading at discount to sector average PE of 52.32

REMUS vs Healthcare Peers — P/E Ratio Comparison

Remus Pharmaceuticals P/E 20.8 vs Healthcare average 52.32, median 29.6 — range 2.0–733.0.

Sector Average
52.32
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low